Belle Mead, NJ, United States of America

Louis John Lombardo

This inventor holds 33 USPTO granted patents and 1 published patent application, plus 2 CIPO patents and 6 EPO patents, primarily in Kinase Inhibitors. Top assignees: Bristol-Myers Squibb Compnay, American Home Products Corporation, Elan Pharmaceuticals, Inc.. Active years: 1990-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Louis John Lombardo. Retrieved from https://idiyas.com/inventor/louis-john-lombardo

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 33 

% Patents Active = 84.8

 

 

Average Co-Inventor Count = 4.4

ph-index = 9

Forward Citations = 360(Granted Patents)


Location History:

  • Middlesex County, NJ (US) (1990)
  • South Plainfield, NJ (US) (1990)
  • Somerset, NJ (US) (1995)
  • Belle Meade, NJ (US) (2002)
  • Belle Mead, NJ (US) (1992 - 2024)

Company Filing History:


Years Active: 1990-2026

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Kinase Inhibitors
Leukocyte Adhesion
Substituted Indole Compounds
Bronchodilators
Dipeptides
Carbamyloxy Compounds
Pyridyl Compounds
Naphthalenyl Compounds
Phenyl Pyrazolidinones
Dihydropyrimidine Compounds
Cyclic Protein Tyrosine Kinase
Triazolo Compounds
33 patents (USPTO):Explore Patents

Title: The Ingenious Mind Behind 32 Patents: Louis John Lombardo

Introduction:

Louis John Lombardo, a brilliant inventor hailing from Belle Mead, NJ, has made a significant mark in the field of innovations with his impressive portfolio of 32 patents. His groundbreaking work has not only showcased his expertise but also contributed to advancements in treating inflammatory and autoimmune diseases.

Latest Patents:

Louis John Lombardo's latest patents revolve around cutting-edge advancements in the medical field. One of his recent inventions involves [1,2,4]triazolo[1,5-a]pyridinyl substituted indole compounds. These compounds have shown promise as inhibitors of signaling through Toll-like receptors 7, 8, or 9, presenting new possibilities in the treatment of inflammatory and autoimmune conditions. Another patent of his focuses on substituted indole compounds, which also exhibit potential in the same therapeutic areas.

Career Highlights:

Having accumulated a total of 32 patents throughout his career, Louis John Lombardo has proven himself as a prolific inventor with a deep understanding of pharmaceutical innovation. He has demonstrated a knack for developing novel compounds and pharmaceutical compositions that have the potential to revolutionize the field of medicine.

Collaborations:

During his career, Louis John Lombardo has collaborated with esteemed professionals in the field. Some of his notable coworkers include Eugene D. Thorsett and Christopher Michael Semko. These collaborations have not only enriched his work but also led to the creation of impactful inventions that have the potential to improve healthcare outcomes.

Conclusion:

Louis John Lombardo's impressive array of patents stands as a testament to his dedication to innovation and his invaluable contributions to the medical community. His groundbreaking work in developing compounds for the treatment of inflammatory and autoimmune diseases highlights his commitment to advancing healthcare solutions. Louis John Lombardo continues to inspire with his inventive spirit, shaping the future of medicine through his pioneering inventions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…